ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is ...
Menarini Silicon Biosystems, a pioneer of cell-based liquid biopsy technology, announced today the publication in Clinical Cancer Research[1] of the CTC biomarker analysis from the PACE trial, a ...
Fluxion Biosciences, Inc. announced today that it has launched a new imaging system, the IsoFlux Cytation Imager, designed to work exclusively with the IsoFlux Liquid Biopsy System and CTC Enumeration ...
ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is delighted ...
The aforementioned enrichment methods are followed by a detection step that will ideally protect the integrity of detected CTCs, allowing additional biological studies. Some methods combine enrichment ...
DUBLIN--(BUSINESS WIRE)--The "Global Circulating Tumor Cells (CTC) Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering. Further developments of various tumor markers that ...
GUILDFORD, SURREY / ACCESS Newswire / January 29, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback